Strands

Premium

Tekmira Data Shows Improvements in SNALP Therapeutic Index, Publishes Data on Cancer Drug Candidate

Tekmira Pharmaceuticals this week announced the presentation of data showing that the therapeutic index of its stable nucleic acid lipid particles could be improved five to ten times over existing versions of the siRNA delivery technology through the incorporation of novel lipids.

The company said the data were unveiled at Asia TIDES Oligonucleotide and Peptide Technology and Product Development Conference in Tokyo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.